Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes

@inproceedings{Edwards2015DulaglutideAE,
  title={Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes},
  author={Krystal L. Edwards and Molly G. Minze},
  booktitle={Core evidence},
  year={2015}
}
INTRODUCTION As the prevalence of type 2 diabetes mellitus (T2DM) is anticipated to continue to rise worldwide, so too are the treatment options also continuing to expand. Current guidelines recommend individualized treatment plans which allow for provider choice and diversity of pharmacotherapeutic regimens. The glucagon-like peptide-1 receptor agonist (GLP-1 RA) class is rapidly expanding, with dulaglutide (Trulicity™) as a once-weekly agent recently approved. AIMS This article examines the… CONTINUE READING
5
Twitter Mentions

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 32 REFERENCES

AACE comprehensive diabetes management algorithm 2013.

  • Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
  • 2013
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus

  • Nature Reviews Endocrinology
  • 2012
VIEW 7 EXCERPTS
HIGHLY INFLUENTIAL